InCube Ventures

InCube Ventures

A life science venture capital firm in California that is focused on investing in healthcare companies that solve clinical unmet needs.

InCube Ventures is a life science venture capital firm in California that is focused on investing in healthcare companies that solve clinical unmet needs. Founded 1995 in San Jose, California, United States by Mir Imran, this company focuses in early and late stage ventures. It usually invests in Series B, Series C and Series D, angel and other venture rounds. Its portfolio companies include WhiteSwell, Channel Medsystems, PLEXUSS, INC., Rani Therapeutics, Channel Medsystems, BodyMedia, Intrapace, Spinal Modulation and Sonoma Orthopedics. The fund's current portfolio includes companies that are developing novel treatment approaches in clinical areas such as atrial fibrillation, epilepsy, gastro intestinal surgery, iron-deficiency anemia, hemorrhagic stroke and metabolic disorders.

Timeline

1995

Founded

Funded Companies

Company
Description
Website
Industry
Location

A company developing women’s healthcare technologies for endometrial ablation

WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .

Metagenomi Technologies, LLC is a Berkeley, California-based company founded by Brian C Thomas.

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Adam Lin

Managing Director

Andrew Farquharson

Managing Director & Co-founder

Bill Ringo

Member

Mar Perez

Principal

Matt Harrison

Investor, Entrepreneur

Mir Imran

Founder & Managing Director

Wayne Roe

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

BodyMedia

Channel Medsystems

Intrapace

PLEXUSS, INC.

Rani Therapeutics

Sonoma Orthopedics

Spinal Modulation

WhiteSwell

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.